These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 494253)

  • 41. Antimicrobial resistance among uropathogens that cause community-acquired urinary tract infections in Bangui, Central African Republic.
    Hima-Lerible H; Ménard D; Talarmin A
    J Antimicrob Chemother; 2003 Jan; 51(1):192-4. PubMed ID: 12493816
    [No Abstract]   [Full Text] [Related]  

  • 42. Fosfomycin: an oral agent for urinary infection caused by extended spectrum beta-lactamase producing organisms.
    Hutley EJ; Chand MA; Hounsome G; Kelsey MC
    J Infect; 2010 Apr; 60(4):308-9. PubMed ID: 20114062
    [No Abstract]   [Full Text] [Related]  

  • 43. Resistance to oral antibiotics in urinary coliform strains isolated between 2000 and 2008 in Sønderborg area, Denmark.
    Cybulski Z; Kjaeldgaard P
    Int J Antimicrob Agents; 2010 May; 35(5):516-7. PubMed ID: 20202798
    [No Abstract]   [Full Text] [Related]  

  • 44. [Etiological factors of urinary tract infections in children].
    Lewczyk E; Drulis-Kawa Z; Doroszkiewicz W; Jankowski S
    Pol Merkur Lekarski; 2001 Nov; 11(65):422-4. PubMed ID: 11852813
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Distribution of ESBL-producing enterobacteria associated to community-acquired monomicrobial urinary tract infections and antimicrobial susceptibility trends over a 9-year period.
    Dias VC; da Silva VL; Firmo Ede O; Bastos LQ; Bastos AN; Bastos RV; Diniz CG
    J Chemother; 2012 Jun; 24(3):178-81. PubMed ID: 22759764
    [No Abstract]   [Full Text] [Related]  

  • 46. Pediatric urinary tract infection. Significance of vaginal bacteria.
    Leadbetter G; Slavin S
    Urology; 1974 May; 3(5):581-8. PubMed ID: 4208559
    [No Abstract]   [Full Text] [Related]  

  • 47. Periurethral enterobacterial carriage preceding urinary infection.
    Brumfitt W; Gargan RA; Hamilton-Miller JM
    Lancet; 1987 Apr; 1(8537):824-6. PubMed ID: 2882232
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Intravenous-only or Intravenous Transitioned to Oral Antimicrobials for Enterobacteriaceae-Associated Bacteremic Urinary Tract Infection.
    Rieger KL; Bosso JA; MacVane SH; Temple Z; Wahlquist A; Bohm N
    Pharmacotherapy; 2017 Nov; 37(11):1479-1483. PubMed ID: 28869655
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Erwinia infection from environmental sources.
    von Graevenitz A
    JAMA; 1971 May; 216(9):1485. PubMed ID: 5108530
    [No Abstract]   [Full Text] [Related]  

  • 50. Detection of extended-spectrum beta-lactamase production in Enterobacteriales from patients with suspected urinary tract infections, Tabora region, Rural Tanzania.
    Nestor D; Malmvall BE; Masonda YP; Msafiri J; Sundqvist M
    APMIS; 2018 Aug; 126(8):700-702. PubMed ID: 30168621
    [No Abstract]   [Full Text] [Related]  

  • 51. [Clinical aspects of urinary tract infection by Serratia marcescens].
    Miyakita H; Kawashima T; Kinoshita H; Kawamura N
    Hinyokika Kiyo; 1984 Feb; 30(2):153-8. PubMed ID: 6377857
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Non-carbapenem therapy of urinary tract infections caused by extended-spectrum β-lactamase-producing Enterobacteriaceae.
    de La Blanchardière A; Dargère S; Guérin F; Daurel C; Saint-Lorant G; Verdon R; Cattoir V
    Med Mal Infect; 2015 May; 45(5):169-72. PubMed ID: 25845927
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Urinary tract infections due to wide spectrum beta lactamase producing enterobacteriaceae].
    Kaltenbach G; Heitz D; Vogel T; Noblet-Dick M; Martin-Hunyadi C; Kiesmann M; Jehl F; Berthel M; Kuntzmann F
    Presse Med; 2002 Aug; 31(26):1211-5. PubMed ID: 12212511
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Prevalence of ESBL strains in urinary tract infections in children in 1996 and 2004].
    Delińska-Galińska A; Kurlenda J; Kozielska E; Borkowska A; Luczak G; Plata-Nazar K
    Przegl Epidemiol; 2006; 60(1):59-64. PubMed ID: 16758740
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Infections with Providence bacilli. A clinical and bacteriologic study.
    Solberg CO; Matsen JM
    Am J Med; 1971 Feb; 50(2):241-6. PubMed ID: 5545459
    [No Abstract]   [Full Text] [Related]  

  • 56. [Bacterial flora and its sensitivity to antibiotics in urinary tract infections in children].
    Szozda G; Nowakowska K
    Probl Med Wieku Rozwoj; 1984; 13():59-67. PubMed ID: 6442420
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Switching from CLSI to EUCAST XL susceptibility breakpoint: its implication in urinary tract infection in men.
    Aguirre-Quiñonero A; Lecaroz Agara MC; Canut Blasco A
    Eur J Clin Microbiol Infect Dis; 2018 Sep; 37(9):1813-1815. PubMed ID: 29936620
    [No Abstract]   [Full Text] [Related]  

  • 58. The nationwide study of bacterial pathogens associated with urinary tract infections conducted by the Japanese Society of Chemotherapy.
    Ishikawa K; Matsumoto T; Yasuda M; Uehara S; Muratani T; Yagisawa M; Sato J; Niki Y; Totsuka K; Sunakawa K; Hanaki H; Hattori R; Terada M; Kozuki T; Maruo A; Morita K; Ogasawara K; Takahashi Y; Matsuda K; Hirose T; Miyao N; Hayashi T; Takeyama K; Kiyota H; Tomita M; Yusu H; Koide H; Kimura S; Yanaoka M; Sato H; Ito T; Deguchi T; Fujimoto Y; Komeda H; Asano Y; Takahashi Y; Ishihara S; Arakawa S; Nakano Y; Tanaka K; Fujisawa M; Matsui T; Fujii A; Yamamoto S; Nojima M; Higuchi Y; Ueda Y; Kanamaru S; Monden K; Tsushima T; Seno Y; Tsugawa M; Takenaka T; Hamasuna R; Fujimoto N; Sho T; Takahashi K; Inatomi H; Takahashi N; Ikei Y; Hayami H; Yamane T; Nakagawa M; Kariya S; Arima T
    J Infect Chemother; 2011 Feb; 17(1):126-38. PubMed ID: 21174142
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparative in vitro activity of cefditoren and other antimicrobials against Enterobacteriaceae causing community-acquired uncomplicated urinary tract infections in women: a Spanish nationwide multicenter study.
    Cuevas O; Cercenado E; Gimeno M; Marín M; Coronel P; Bouza E;
    Diagn Microbiol Infect Dis; 2010 Jul; 67(3):251-60. PubMed ID: 20542206
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Urinary tract infection caused by Kluyvera ascorbata in an immunocompromised patient: case report and review.
    Torre D; Crespi E; Bernasconi M; Rapazzini P
    Scand J Infect Dis; 2005; 37(5):375-8. PubMed ID: 16051578
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.